Cite
MLA Citation
E Monnet et al.. “Evidence of NI‐0101 pharmacological activity, an anti‐TLR4 antibody, in a randomized phase I dose escalation study in healthy volunteers receiving LPS.” Clinical pharmacology & therapeutics, vol. 101, no. 2, 2017, pp. 200–208. http://access.bl.uk/ark:/81055/vdc_100040596595.0x000058